Human liver organoids for disease modeling of fibrolamellar carcinoma-Reference-Cited by-同舟云学术

Human liver organoids for disease modeling of fibrolamellar carcinoma

Published:2022-08 Issue:8 Volume:17 Page:1874-1888
ISSN:2213-6711
Container-title:Stem Cell Reports
language:en
Short-container-title:Stem Cell Reports

Author:

Narayan Nicole J.C.,Requena David,Lalazar Gadi,Ramos-Espiritu Lavoisier,Ng Denise,Levin Solomon,Shebl Bassem,Wang Ruisi,Hammond William J.,Saltsman James A.,Gehart Helmuth,Torbenson Michael S.,Clevers Hans,LaQuaglia Michael P.,Simon Sanford M.

Publisher

Elsevier BV

Subject

Cell Biology,Developmental Biology,Genetics,Biochemistry

Reference58 articles.

1. Fibrolamellar hepatocellular carcinoma: an immunohistochemical comparison with conventional hepatocellular carcinoma;Abdul-Al;Int. J. Surg. Pathol.,2010

2. Human primary liver cancer-derived organoid cultures for disease modeling and drug screening;Broutier;Nat. Med.,2017

3. An organoid biobank for childhood kidney cancers that captures disease and tissue heterogeneity;Calandrini;Nat. Commun.,2020

4. Tumor organoid-T-cell coculture systems;Cattaneo;Nat. Protoc.,2020

5. Fibrolamellar carcinoma of the liver: a tumor of adolescents and young adults with distinctive clinico-pathologic features;Craig;Cancer,1980

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Organoid as a promising tool for primary liver cancer research: a comprehensive review;Cell & Bioscience;2024-08-27

2. Patient-derived organoid models to decode liver pathophysiology;Trends in Endocrinology & Metabolism;2024-08

3. Human Hepatobiliary Organoids: Recent Advances in Drug Toxicity Verification and Drug Screening;Biomolecules;2024-07-04

4. Tumor Organoids for Primary Liver Cancers: A Systematic Review of Current Applications in Diagnostics, Disease Modeling, and Drug Screening;JHEP Reports;2024-07

5. Research progress and application of liver organoids for disease modeling and regenerative therapy;Journal of Molecular Medicine;2024-05-28